9 reports

With the expanding repertoire of drugs for anti-HBV and anti-HCV therapies, monitoring the emergence of antiviral resistance has become increasingly important.

  • Molecular Diagnostics
  • North America
  • bioMerieux S.A.
  • Cepheid
  • Hologic, Inc.

RESPIRATORY TRACT INFECTIONS HAVE BEEN A LEADING TARGET FOR MOLECULAR ASSAY DEVELOPMENT, INCLUDING INFLUENZA, GROUP A STREPTOCOCCUS (STREP A) AND RSV, IN ORDER TO INFORM ANTIBIOTIC AND ANTIVIRAL THERAPY.

  • Molecular Diagnostics
  • North America
  • Beckman Coulter, Inc.
  • Danaher Corporation
  • Roche Group

Global Influenza Market: Size, Trends & Forecasts (2018-2022) NOVEMBER 2018 ##.

  • Molecular Diagnostics
  • Vaccine
  • North America
  • Market Size
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS ##.

  • Biotech Diagnostics
  • Diagnostics
  • Molecular Diagnostics
  • North America
  • Market Size

It is World' s No. ## in terms of premium market research studies published annually.

  • Genetic Testing
  • Molecular Diagnostics
  • North America
  • Forecast
  • Quest Diagnostics Incorporated

QIAGEN also offers a much longer list of PCR-based antiviral tests for transplantation testing outside the U. S.

  • Biotech Diagnostics
  • Blood Supply
  • Molecular Diagnostics
  • North America
  • Biocartis S.A.
  • EUROPE: INFLUENZA DIAGNOSTICS MARKET SIZE FOR SAMBA, BY COUNTRY, 2014-2021 (USD MILLION)

Q. ##.

  • Influenza
  • Molecular Diagnostics
  • North America
  • Market Size
  • Alere Inc.

ONE UNIT REFERS TO ONE ML.

  • Allergy
  • Molecular Diagnostics
  • North America
  • Forecast
  • QIAGEN N.V.

Product Launch ## ##. ## ##. ## R E C E N T D E V E L O P M E N T S ## ##. ## ##. ##. ## P r o d u c t l a u n c h e s Segment Year Nature of Agreement ## ##. ## ##. ##. ## A c q u i s i t i o n s Year Company ## Company ## Synergy

  • Medical Device
  • Molecular Diagnostics
  • North America
  • Market Size
  • Roche Group